Sreekanth Chalasani is associate professor in the Molecular Neurobiology Laboratory at the Salk Institute for Biological Studies in La Jolla, California
Sreekanth Chalasani
Associate professor
Salk Institute for Biological Studies
From this contributor
Controlling neurons with ultrasound: Q&A with Sreekanth Chalasani
The new method, called sonogenetics, noninvasively manipulates neural circuits in mice.
Controlling neurons with ultrasound: Q&A with Sreekanth Chalasani
By
Niko McCarty
1 March 2022 | 7 min read
Explore more from The Transmitter
Securing the academic pipeline amid uncertain U.S. funding climate
Finding creative ways to keep early-career researchers in academia—for example, through part-time roles—can help the field weather the storm.
Securing the academic pipeline amid uncertain U.S. funding climate
Finding creative ways to keep early-career researchers in academia—for example, through part-time roles—can help the field weather the storm.
By
Lucina Q. Uddin
9 March 2026 | 4 min read
Let’s teach neuroscientists how to be thoughtful and fair reviewers
Blanco-Suárez revamped the traditional journal club by developing a course in which students peer review preprints alongside the published papers that evolved from them.
Let’s teach neuroscientists how to be thoughtful and fair reviewers
Blanco-Suárez revamped the traditional journal club by developing a course in which students peer review preprints alongside the published papers that evolved from them.
By
Elena Blanco-Suárez
6 March 2026 | 6 min read
New autism committee positions itself as science-backed alternative to government group
The Independent Autism Coordinating Committee plans to meet at the same time as the U.S. federal Interagency Autism Coordinating Committee later this month—and offer its own research agenda.
New autism committee positions itself as science-backed alternative to government group
The Independent Autism Coordinating Committee plans to meet at the same time as the U.S. federal Interagency Autism Coordinating Committee later this month—and offer its own research agenda.
By
Angie Voyles Askham
5 March 2026 | 5 min read